Annual report for Fisher & Paykel Healthcare for the 2025 financial year.
4 July 2025
Full Year Dividend
23 July 2025
Investor Event
21 August 2025*
Annual Shareholders' Meeting
30 September 2025
Financial Half Year End
† Dividends are subject to Board determination
*Indicative date. Subject to final confirmation
26 November 2025*
Half Year Results Announcement
December 2025
Interim Dividend†
31 March 2026
2026 Financial Year End
May 2026
Full Year Results Announcement
A short overview of Fisher & Paykel Healthcare's history, financial performance, business areas and management team.
Shareholders should address questions relating to dividends, certificates or changes of address to Fisher & Paykel Healthcare's share registrar, MUFG Pension & Market Services.
MUFG Pension & Market Services (NZ) Limited
Level 30, PwC Tower, 15 Customs Street West, Auckland 1010, New Zealand
Postal: PO Box 91976, Auckland 1142, New Zealand
Investor enquiries: +64 9 375 5998
Fax: +64 9 375 5990
Website: www.mpms.mufg.com
Email: enquiries.nz@cm.mpms.mufg.com
MUFG Pension & Market Services (AU) Limited
Level 12, 680 George Street, Sydney, NSW 2000, Australia
Postal: Locked Bag A14, Sydney South, NSW 1235, Australia
Investor enquiries: +61 2 8280 7111
Fax: +61 2 9287 0303
Website: www.mpms.mufg.com
Email: enquiries.nz@cm.mpms.mufg.com
For all other investor inquiries contact
Email: investor@fphcare.co.nz
Phone: +64 9 574 0123 Ext: 5396
Fisher & Paykel Healthcare 15 Maurice Paykel Place East Tamaki, Auckland 2013 PO Box 14 348 Panmure, Auckland 1741 New Zealand |
Fisher & Paykel Healthcare is listed on the NZX Main Board and Australian Securities Exchange and is governed by the rules of those exchanges. Fisher & Paykel Healthcare does not sponsor, sanction, support or encourage trading in Fisher & Paykel Healthcare shares through third and fourth markets, such as ADR programmes and over the counter trading. Fisher & Paykel Healthcare disclaims any liability whatsoever arising out of any trading through third and fourth markets, including unsponsored ADR programmes and over the counter trading.
Sign up to receive email notifications of the latest investor news from Fisher & Paykel Healthcare.